Is BNB PLUS CORP. (BNBX) Halal?

NASDAQ Financial Services United States $4M
✗ NOT HALAL
Confidence: 95/100
BNB PLUS CORP. (BNBX) is Not Halal under AAOIFI Standard 21 due to its classification in the Asset Management industry, which is excluded under Shariah screening. Companies operating in prohibited sectors such as conventional banking, insurance, alcohol, tobacco, and gambling are automatically excluded regardless of their financial ratios.

Shariah Screening — 5 Standards

Based on financial data from September 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI Excluded — Asset Management ✗ NOT HALAL
DJIM Excluded — Asset Management ✗ NOT HALAL
MSCI Excluded — Asset Management ✗ NOT HALAL
S&P Excluded — Asset Management ✗ NOT HALAL
FTSE Excluded — Asset Management ✗ NOT HALAL

Financial Highlights

P/E Ratio
0.0
EPS
$282.39
P/B Ratio
0.2
EV/EBITDA
-0.0
EV: $980,860
Revenue
$2M
Growth: -35.0%
Beta
0.7
Low volatility
Current Ratio
2.3

Profitability

Gross Margin 29.9%
Operating Margin -3248.8%
Net Margin 0.0%
Return on Equity (ROE) -199.1%
Return on Assets (ROA) -98.0%

Cash Flow & Balance Sheet

Operating Cash Flow-$13M
Free Cash Flow-$13M
Total Debt$193,250
Debt-to-Equity0.3
Current Ratio2.3
Total Assets$4M

Price & Trading

Last Close$0.69
50-Day MA$0.97
200-Day MA$2.92
Avg Volume140K
Beta0.7
52-Week Range
$0.61
$30.90

About BNB PLUS CORP. (BNBX)

CEO
Ms. Judith Murrah
Employees
26
Sector
Financial Services
Industry
Asset Management
Country
United States
Exchange
NASDAQ
Market Cap
$4M
Currency
USD

BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. BNB Plus Corp. was formerly known as Applied DNA Sciences, Inc. and changed its name to BNB Plus Corp. in November 2025. The company was founded in 1983 and is based in Stony Brook, New York.

Related Halal Stocks in Financial Services

Frequently Asked Questions

Is BNB PLUS CORP. (BNBX) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), BNB PLUS CORP. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is BNB PLUS CORP.'s debt ratio?

BNB PLUS CORP.'s debt ratio is not available under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%.

What are BNB PLUS CORP.'s key financial metrics?

BNB PLUS CORP. has a market capitalization of $4M, trailing P/E ratio of 0.0, and revenue of $2M. Return on equity stands at -199.1%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.